Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Orthodontic study cast analysis--reproducibility of recordings and agreement between conventional and 3D virtual measurements.

Sjögren AP, Lindgren JE, Huggare JA.

J Digit Imaging. 2010 Aug;23(4):482-92. doi: 10.1007/s10278-009-9211-y. Epub 2009 Jun 13.

2.

Relationship between brain levels of 3-(3-hydroxyphenyl)-N-n-propylpiperidine HCl enantiomers and effects on locomotor activity in rats.

Lundström J, Lindgren JE, Ahlenius S, Hillegaart V.

J Pharmacol Exp Ther. 1992 Jul;262(1):41-7.

PMID:
1352554
3.

Single-dose kinetics of deuterium-labelled cannabinol in man after intravenous administration and smoking.

Johansson E, Ohlsson A, Lindgren JE, Agurell S, Gillespie H, Hollister LE.

Biomed Environ Mass Spectrom. 1987 Sep;14(9):495-9.

PMID:
2960395
4.

Pressor response of oral tyramine in healthy men given amiflamine and placebo.

Grind M, Siwers B, Graffner C, Alván G, Gustafsson LL, Helleday J, Lindgren JE, Ogenstad S, Selander H.

Clin Pharmacol Ther. 1986 Aug;40(2):155-60.

PMID:
3731679
5.

Tolerance and pilot pharmacokinetics of amiflamine after increasing single oral doses in healthy subjects.

Alván G, Graffner C, Grind M, Gustafsson LL, Lindgren JE, Nordin C, Ross S, Selander H, Siwers B.

Clin Pharmacol Ther. 1986 Jul;40(1):81-5.

PMID:
3720180
6.

Pharmacokinetics and metabolism of delta 1-tetrahydrocannabinol and other cannabinoids with emphasis on man.

Agurell S, Halldin M, Lindgren JE, Ohlsson A, Widman M, Gillespie H, Hollister L.

Pharmacol Rev. 1986 Mar;38(1):21-43. Review. No abstract available.

PMID:
3012605
7.

Single-dose kinetics of deuterium-labelled cannabidiol in man after smoking and intravenous administration.

Ohlsson A, Lindgren JE, Andersson S, Agurell S, Gillespie H, Hollister LE.

Biomed Environ Mass Spectrom. 1986 Feb;13(2):77-83.

PMID:
2937482
8.

Correlations between in vitro dissolution rate and bioavailability of alaproclate tablets.

Graffner C, Nicklasson M, Lindgren JE.

J Pharmacokinet Biopharm. 1984 Aug;12(4):367-80.

PMID:
6527230
9.

Guide to the analysis of phencyclidine and its metabolites in biological material.

Lindgren JE, Holmstedt B.

Arch Toxicol Suppl. 1983;6:61-73.

PMID:
6578750
10.

Quantification of delta 1-tetrahydrocannabinol in tissues and body fluids.

Lindgren JE.

Arch Toxicol Suppl. 1983;6:74-80.

PMID:
6312925
11.

Identification of in vitro metabolites of delta 1-tetrahydrocannabinol formed by human livers.

Halldin MM, Widman M, V Bahr C, Lindgren JE, Martin BR.

Drug Metab Dispos. 1982 Jul-Aug;10(4):297-301.

PMID:
6126323
12.

Single dose kinetics of deuterium labelled delta 1-tetrahydrocannabinol in heavy and light cannabis users.

Ohlsson A, Lindgren JE, Wahlén A, Agurell S, Hollister LE, Gillespie HK.

Biomed Mass Spectrom. 1982 Jan;9(1):6-10.

PMID:
6277407
13.

Interactions of delta 1-tetrahydrocannabinol with cannabinol and cannabidiol following oral administration in man. Assay of cannabinol and cannabidiol by mass fragmentography.

Agurell S, Carlsson S, Lindgren JE, Ohlsson A, Gillespie H, Hollister L.

Experientia. 1981 Oct 15;37(10):1090-2. No abstract available.

PMID:
6273208
14.

Do plasma concentrations of delta 9-tetrahydrocannabinol reflect the degree of intoxication?

Hollister LE, Gillespie HK, Ohlsson A, Lindgren JE, Wahlen A, Agurell S.

J Clin Pharmacol. 1981 Aug-Sep;21(S1):171S-177S.

PMID:
6271822
15.

Guide to the analysis of cocaine and its metabolites in biological material.

Lindgren JE.

J Ethnopharmacol. 1981 Mar-May;3(2-3):337-51. Review. No abstract available.

PMID:
7017290
16.

Plasma levels of delta 9-tetrahydrocannabinol after intravenous, oral, and smoke administration.

Ohlsson A, Lindgren JE, Wahlen A, Agurell S, Hollister LE, Gillespie HK.

NIDA Res Monogr. 1981 Feb;34:250-6. No abstract available.

PMID:
6261133
17.

Clinical effects and plasma levels of delta 9-tetrahydrocannabinol (delta 9-THC) in heavy and light users of cannabis.

Lindgren JE, Ohlsson A, Agurell S, Hollister L, Gillespie H.

Psychopharmacology (Berl). 1981;74(3):208-12.

PMID:
6267648
18.

Plasma delta-9 tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking.

Ohlsson A, Lindgren JE, Wahlen A, Agurell S, Hollister LE, Gillespie HK.

Clin Pharmacol Ther. 1980 Sep;28(3):409-16.

PMID:
6250760
19.

Chemical synthesis and biological occurrence of carboxylic acid metabolites of delta1(6)-tetrahydrocannabinol.

Agurell S, Edward C, Halldin M, Leander K, Levy S, Lindgren JE, Mechoulam R, Noreqvist M, Ohlsson A.

Drug Metab Dispos. 1979 May-Jun;7(3):155-61.

PMID:
38086
20.

Acidic metabolites of delta1-tetrahydrocannabinol isolated from rabbit urine.

Nordqvist M, Lindgren JE, Agurell S.

J Pharm Pharmacol. 1979 Apr;31(4):231-7.

PMID:
36462
21.

Cocaine in blood of coca chewers.

Homstedt B, Lindgren JE, Rivier L, Plowman T.

J Ethnopharmacol. 1979 Jan;1(1):69-78.

PMID:
544950
22.

Simultaneous GLC determination of zimelidine and norzimelidine. Synthesis of secondary amines as closely related internal standards.

Högberg K, Lindgren JE, Högberg T, Ulff B.

Acta Pharm Suec. 1979;16(5):299-308. No abstract available.

PMID:
539440
23.

Pharmacokinetics of clomethiazole in healthy adults.

Jostell KG, Agurell S, Allgén LG, Kuylenstierna B, Lindgren JE, Aberg G, Osterlöf G.

Acta Pharmacol Toxicol (Copenh). 1978 Sep;43(3):180-9.

PMID:
707131
24.

Introduction to quantification of cannabinoids and their metabolites in biological fluids.

Agurell S, Lindgren JE, Ohlsson A.

Adv Biosci. 1978 Jul 22-23;22-23:3-13. No abstract available.

PMID:
756831
25.

In vivo metabolites of cannabinol identified as fatty acid conjugates.

Yisak W, Agurell S, Lindgren JE, Widman M.

J Pharm Pharmacol. 1978 Jul;30(7):462-3. No abstract available.

PMID:
27621
26.

Peyote alkaloids: identification in a prehistoric specimen of lophophora from coahuila, Mexico.

Bruhn JG, Lindgren JE, Holmstedt B, Adovasio JM.

Science. 1978 Mar 31;199(4336):1437-8.

PMID:
17796678
27.

Neutral in vivo metabolites of cannabinol isolated from rat faeces.

Yisak WA, Widman M, Lindgren JE, Agurell S.

J Pharm Pharmacol. 1977 Aug;29(8):487-90.

PMID:
19598
28.

In vivo neutral metabolites of cannabinol from rat faeces [proceedings].

Yisak WA, Widman M, Agurell S, Lindgren JE.

West Afr J Pharmacol Drug Res. 1977 Jun;4(1):61P. No abstract available.

PMID:
602189
29.

Determination of ketocaine blood concentrations following brachial plexus block and epicutaneous administration.

Berlin-Wahlén A, Högberg K, Lindgren JE, Vecchietti M.

Acta Pharm Suec. 1977;14(5-6):425-34. No abstract available.

PMID:
596161
30.

Mass fragmentographic identification of O-Methylcorpalline in Pilosocereus guerreronis.

Lindgren JE, Bruhn JG.

Lloydia. 1976 Nov-Dec;39(6):464-6. No abstract available.

PMID:
1026848
31.

Dioxygenated metabolites of cannabidiol formed by rat liver.

Martin B, Agurell S, Nordqvist M, Lindgren JE.

J Pharm Pharmacol. 1976 Aug;28(8):603-8.

PMID:
11306
32.

A method for the identification of acid metabolites of tetrahydrocannabinol (THC) by mass fragmentography.

Nordqvist M, Lindgren JE, Agurell S.

NIDA Res Monogr. 1976 May;(7):64-9. No abstract available.

PMID:
967241
33.

Detection and quantification of tetrahydrocannabinol in blood plasma.

Ohlsson A, Lindgren JE, Leander K, Agurell S.

NIDA Res Monogr. 1976 May;(7):48-63. No abstract available.

PMID:
967240
34.

Identification of monohydroxylated metabolites of cannabidiol formed by rat liver.

Martin B, Nordqvist M, Agurell S, Lindgren JE, Leander K, Binder M.

J Pharm Pharmacol. 1976 Apr;28(4):275-9.

PMID:
6714
35.

Cactaceae alkaloids. XXIII. Alkaloids of Pachycereus pecten-aboriginum and Cereus jamacaru.

Bruhn JG, Lindgren JE.

Lloydia. 1976 Mar-Jun;39(2-3):175-7. No abstract available.

PMID:
948243
36.

Plasma concentrations and effects of methaqualone after single and multiple oral doses in man.

Alván G, Ericsson O, Levander S, Lindgren JE.

Eur J Clin Pharmacol. 1974 Oct 4;7(6):449-54. No abstract available.

PMID:
4439868
37.

[Methaqualone--story about a sleeping medicine].

Alván G, Holmstedt B, Lindgren JE.

Lakartidningen. 1974 Oct 3;71(40):3777-80. Swedish. No abstract available.

PMID:
4410125
38.

Monohydroxylated metabolites of delta-1-tetrahydrocannabinol in mouse brain. Comparison with in vitro liver metabolites.

Jones G, Widman M, Agurell S, Lindgren JE.

Acta Pharm Suec. 1974 Jun;11(3):283-94. No abstract available.

PMID:
4839738
39.

Biliary excretion of delta1-tetrahydrocannabinol and its metabolites in the rat.

Widman M, Nordqvist M, Agurell S, Lindgren JE, Sandberg F.

Biochem Pharmacol. 1974 Apr 1;23(7):1163-72. No abstract available.

PMID:
4823449
40.

Metabolism of pentachlorophenol.

Ahlborg UG, Lindgren JE, Mercier M.

Arch Toxicol. 1974;32(4):271-81. No abstract available.

PMID:
4480027
41.

[Identification of potential cannalis containing substance metabolites: nuclear resonance and mass spectroscopic studies on side chain hydroxylation of cannabinoids].

Binder M, Agurell S, Leander K, Lindgren JE.

Helv Chim Acta. 1974;57(6):1626-41. German. No abstract available.

PMID:
4465340
42.

Plasma and cerebrospinal fluid concentrations of pentazocine in patients: assay by mass fragmentography.

Agurell S, Boréus LO, Gordon E, Lindgren JE, Ehrnebo M, Lönroth U.

J Pharm Pharmacol. 1974 Jan;26(1):1-8. No abstract available.

PMID:
4150929
43.

Plasma kinetics of methaqualone in man after single oral doses.

Alván G, Lindgren JE, Bogentoft C, Ericsson O.

Eur J Clin Pharmacol. 1973 Oct;6(3):187-90. No abstract available.

PMID:
4762057
44.

Analysis of "morphine base".

Hanson A, Lindgren JE.

Arch Toxikol. 1973 Aug 30;31(1):1-6. No abstract available.

PMID:
4747542
45.

Quantitation of 1-tetrahydrocannabinol in plasma from cannabis smokers.

Agurell S, Gustafsson B, Holmstedt B, Leander K, Lindgren JE, Nilsson I, Sandberg F, Asberg M.

J Pharm Pharmacol. 1973 Jul;25(7):554-8. No abstract available.

PMID:
4147053
46.

Metabolism of 7-hydroxy- 1(6)-tetrahydrocannabinol in the rabbit.

Nilsson IM, Aqurell S, Nilsson JL, Ohlsson A, Lindgren JE, Mechoulam R.

Acta Pharm Suec. 1973 May;10(2):97-106. No abstract available.

PMID:
4781925
47.

Quantitative determination of 5-hydroxyindole-3-acetic acid in cerebrospinal fluid by gas chromatography-mass spectrometry.

Bertilsson L, Atkinson AJ Jr, Althaus JR, Härfast A, Lindgren JE, Holmstedt B.

Anal Chem. 1972 Jul;44(8):1434-8. No abstract available.

PMID:
5083849
48.

Mass spectrometry of methaqualone metabolites. Fragmentation patterns of the monohydroxy derivatives.

Bogentoft C, Ericsson O, Danielsson B, Lindgren JE, Holmstedt B.

Acta Pharm Suec. 1972 Apr;9(2):151-4. No abstract available.

PMID:
5030543
49.

Detection of biochemical intermediates by mass fragmentography: Mescaline and tetrahydroisoquinoline precursors.

Lindgren JE, Agurell S, Lundström J, Svensson U.

FEBS Lett. 1971 Feb 12;13(1):21-27. No abstract available.

50.

Metabolism of 5-methoxy-N,-N dimethyltryptamine- 14 C in the rat.

Agurell S, Holmstedt B, Lindgren JE.

Biochem Pharmacol. 1969 Oct;18(10):2771-81. No abstract available.

PMID:
5404007

Supplemental Content

Loading ...
Support Center